CORZ Form 4: Todd DuChene withholds 8,228 shares for taxes

Rhea-AI Filing Summary

Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc. (CORZ), reported a transaction on 09/30/2025 showing 8,228 shares of Common Stock disposed at a price of $17.94. The Form indicates these shares were withheld to satisfy tax withholding obligations on vested restricted stock units. After the reported transaction, Mr. DuChene beneficially owns 2,021,428 shares, reported as direct ownership. The Form 4 was signed on 10/02/2025.

Positive

• Continued large direct ownership: Reporting person holds 2,021,428 shares after the transaction

Negative

• Disposition of shares: 8,228 shares were disposed at $17.94, reducing the reporting person's holdings

Insights

Corporate Insider/Equity Compensation Analyst

Routine tax-withholding sale after RSU vesting; large remaining direct stake.

The filing shows 8,228 shares were disposed on 09/30/2025 as a tax-withholding action tied to vested restricted stock units, not an open-market discretionary sale. Such withholding is a common administrative step when restricted awards vest.

Despite the disposition, the reporting person retains a substantial direct position of 2,021,428 shares, indicating continued significant ownership.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DUCHENE TODD M

Role See remarks

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	8,228	$17.94	$148K

Holdings After Transaction: Common Stock — 2,021,428 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

DUCHENE TODD M

(Last) (First) (Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER DE 19904

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		F(1)		8,228	D	$17.94	2,021,428	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

Remarks:

Chief Legal and Administrative Officer

	/s/ Todd DuChene	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Core Scientific insider Todd DuChene report on Form 4 (CORZ)?

The Form 4 reports that Todd DuChene disposed of 8,228 shares on 09/30/2025 at $17.94, withheld to satisfy tax obligations from RSU vesting.

Why were the 8,228 shares disposed according to the filing?

The filing states the shares were withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

How many shares does Todd DuChene beneficially own after the transaction?

After the reported transaction, Mr. DuChene beneficially owns 2,021,428 shares (direct ownership).

When was the Form 4 signed and filed?

The signature on the Form 4 is dated 10/02/2025; the transaction date reported is 09/30/2025.

Was this an open-market sale or an administrative withholding?

The Form 4 explanation specifies the disposition represents shares withheld for tax withholding on vested restricted stock units, not an open-market discretionary sale.